BOIRF (Boiron) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 26, 2026)


BOIRF Boiron SA BOIRF
62 GF Score
Price $31.90
GF Value $33.65
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Boiron Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Boiron's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

BOIRF vs ZTS, UTHR, VTRS: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Boiron's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Boiron Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Boiron's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Boiron's Margin of Safety % (DCF FCF Based) falls into.


BOIRF
62GF Score
Boiron SA BOIRF
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Boiron (BOIRF) Overvalued in 2026?

Based on GuruFocus' analysis, Boiron stock appears to be undervalued. The current stock price of $31.90 is trading 5.2% below its estimated GF Value™ of $33.65. GuruFocus considers Boiron to be Fairly Valued.

Key valuation signals for BOIRF:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $33.65 vs. price of $31.90 (5.2% below fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the BOIRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Boiron Business Description

Address 2, Avenue de l’Ouest Lyonnais No. 039, Messimy, FRA, 69510
Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.
62GF Score

Get the complete analysis for BOIRF

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$31.90
Price
$33.65
GF Value